Digital Health
This morning BioIQ, a health-testing and biometric-screening technology company, released its at-home COVID-19, Flu A/Flu B, and 21 Test Respiratory Panel saliva test.
The news comes months after reports that the company had furloughed staff and couldn't secure additional funding for its-ingestible sensor business.
From virtual management programs to hybrid closed loop systems, diabetes management companies put the spotlight on improved blood glucose management and positive clinical outcomes.
RapidSOS received $21 million in funding, the emergency response technology company announced today.
Investors are no longer meeting new partners face to face, but primed funds and new demand for converging digital products still fuel new deals.
Experts say that adopting an effective digital strategy is necessary for a company’s survival.
Also: A deep dive on Verily's Project Baseline; Intermountain Healthcare launches home-monitoring program.
The study found that the flash continuous glucose monitoring system can cost about 60% less than traditional methods.
The research effort is a collaboration with nonprofit 4YouandMe, and will collect self-reported symptoms and wearables data from 300 high-risk participants.
Healthcare providers use a web interface to prescribe an initial dose "and BlueStar does the rest," according to Welldoc's chief medical officer.